Rarity Health is an independently owned healthcare communications agency that specializes in launching rare disease products. With more than 30 years of success in the rare disease space, Rarity Health has developed a blueprint, Rarity Launchpad, for product launches that is highly customizable for each brand. Having a deep knowledge of the complexities of launching rare disease therapies, Rarity Health can provide a clear path ensuring launch success.
We leverage deep market insights, strategy, and science with dynamic creative execution and innovative digital tactics to serve our clients in the biotech, and pharmaceutical industries. Rarity employs a patient-centric model providing inherent buy-in from the community to ensure rare disease product launches that exceed expectations. From pre-launch to launch and re-launch, it’s rare—well done.
We are a team of dedicated listeners.
We build upon client initiatives and key strategies to increase brand equity.
We energize and engage through brand storytelling.
We position ourselves as the most valued brand advocate.
If you’re looking to work with an agency that listens to, engages with, creates for, and partners with successful brands, look no further.
Take a step in the right direction, and see what we can do for you.
"I've been working with the founders and staff of Rarity Health for many years. They are extremely professional and committed to working closely with their clients. Rarity Health puts the time and energy required into satisfying customers needs it a timely manner - very deadline oriented.... Rarity Health is extremely proficient at strategizing and the creative development of marketing programs. They have extensive experience in Brand Management; I have utilized the team for numerous product launches in the Pharma space...Great people to work with!"
"Rarity Health is a great organization with outstanding, customer-oriented staff, going the extra-mile to find the optimal solution for your rare disease audience."
"Creative thinkers who are able to deliver on new, big ideas for the rare disease community."